GE HealthCare Technologies/$GEHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ticker
$GEHC
Sector
Primary listing
Employees
53,000
Headquarters
Website
GEHC Metrics
BasicAdvanced
$36B
16.01
$4.88
1.28
$0.14
0.18%
Price and volume
Market cap
$36B
Beta
1.28
52-week high
$94.80
52-week low
$57.65
Average daily volume
3M
Dividend rate
$0.14
Financial strength
Current ratio
1.16
Quick ratio
0.832
Long term debt to equity
86.245
Total debt to equity
107.666
Dividend payout ratio (TTM)
2.63%
Interest coverage (TTM)
7.42%
Profitability
EBITDA (TTM)
3,674
Gross margin (TTM)
41.56%
Net profit margin (TTM)
11.22%
Operating margin (TTM)
15.56%
Effective tax rate (TTM)
17.17%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
5.77%
Return on equity (TTM)
25.80%
Valuation
Price to earnings (TTM)
16.012
Price to revenue (TTM)
1.786
Price to book
3.67
Price to tangible book (TTM)
-7.24
Price to free cash flow (TTM)
22.793
Free cash flow yield (TTM)
4.39%
Free cash flow per share (TTM)
3.428
Dividend yield (TTM)
0.17%
Forward dividend yield
0.18%
Growth
Revenue change (TTM)
2.31%
Earnings per share change (TTM)
41.40%
3-year revenue growth (CAGR)
4.06%
3-year earnings per share growth (CAGR)
4.31%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
Bulls say / Bears say
GE HealthCare cut its full-year profit forecast to $3.90–$4.10 per share, down from $4.61–$4.75, citing rising global trade tensions and tariffs that could reduce earnings by $0.85, highlighting margin pressure. (Reuters)
A U.S. Commerce Department probe under Section 232 into medical device imports could result in higher tariffs on equipment and supplies, creating uncertainty for GE HealthCare’s global supply chain and costs. (Reuters)
GE HealthCare is considering the sale or a partial stake sale of its China unit after a 15% drop in 2024 revenue, underscoring regulatory challenges, tariff burdens, and growing domestic competition facing its China business recovery. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
GEHC News
AllArticlesVideos
GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care
Business Wire6 days ago
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
Business Wire2 weeks ago
University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for GE HealthCare Technologies stock?
GE HealthCare Technologies (GEHC) has a market cap of $36B as of October 26, 2025.
What is the P/E ratio for GE HealthCare Technologies stock?
The price to earnings (P/E) ratio for GE HealthCare Technologies (GEHC) stock is 16.01 as of October 26, 2025.
Does GE HealthCare Technologies stock pay dividends?
Yes, the GE HealthCare Technologies (GEHC) stock pays dividends to shareholders. As of October 26, 2025, the dividend rate is $0.135 and the yield is 0.18%. GE HealthCare Technologies has a payout ratio of 2.63% on a trailing twelve-month basis.
When is the next GE HealthCare Technologies dividend payment date?
The next GE HealthCare Technologies (GEHC) dividend payment is scheduled for November 14, 2025.
What is the beta indicator for GE HealthCare Technologies?
GE HealthCare Technologies (GEHC) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.